Clinical Trials Browser

INDUSTRY × Panitumumab × Genitourinary × Clear all

NCT00425035 2013-05-13

Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2

Phase 2 Completed

Kidney Neoplasms

NCT00425204 2008-09-15

Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

Phase 2 Completed

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Colorectal Neoplasms

NCT00061126 2005-06-24

ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body

Phase 2 Completed

Prostatic Neoplasms